Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia.
Harrison CN; Campbell PJ; Buck G; Wheatley K; East CL; Bareford D; Wilkins BS; van der Walt JD; Reilly JT; Grigg AP; Revell P; Woodcock BE; Green AR; The New England Journal Of Medicine, 2005, vol. 353, issue 1, p 33, ISSN 15334406. ISBN 15334406.
Full Text Resources Located for this Citation